clinical features and outcomes of serotype 19a invasive pneumococcal disease in calgary, alberta
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

clinical features and outcomes of serotype 19a invasive pneumococcal disease in calgary, alberta

;Leah J Ricketson;Otto G Vanderkooi;Melissa L Wood;Jenine Leal;James D Kellner
zdravstveno varstvo 2014 Vol. 25 pp. e71-e75
139
ricketson2014canadianclinical

Abstract

BACKGROUND: Streptoccocus pneumoniae serotype 19A (ST19A) became an important cause of invasive pneumococcal disease (IPD) after the introduction of the conjugate vaccine.

Keywords

infectious and parasitic diseasesmicrobiology

Access

DOI:
10.1155/2014/196748
URL:
http://dx.doi.org/10.1155/2014/196748

Citation

ID: 163043
Ref Key: ricketson2014canadianclinical
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
163043
Unique Identifier:
10.1155/2014/196748
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store